Lipid nanoparticulate drug delivery system for the treatment of hepatic fibrosis
<p>Background: Irreversible hepatic fibrosis, an excessive production and accumulation of extra cellular matrix by hepatic stellate cells in the liver, becomes a remarkable economic burden in global health care system.Low therapeutic efficacy and undesirable systemic effect of conventional the...
Saved in:
Main Authors: | Swarupananda Mukherjee (Author), Ayon Dutta (Author), Dipanjana Ash (Author) |
---|---|
Format: | Book |
Published: |
Archives of Hepatitis Research - Peertechz Publications,
2021-01-28.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipid Nanoparticulate Drug Delivery Systems: Recent Advances in the Treatment of Skin Disorders
by: Stefan R. Stefanov, et al.
Published: (2021) -
Emerging transporter-targeted nanoparticulate drug delivery systems
by: Hongyan Su, et al.
Published: (2019) -
Addressing barriers in diffuse intrinsic pontine glioma: the transformative role of lipid nanoparticulate drug delivery
by: Zenab Presswala, et al.
Published: (2024) -
Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy
by: Yukun Huang, et al.
Published: (2018) -
Functionalization of Nanoparticulate Drug Delivery Systems and Its Influence in Cancer Therapy
by: Theodora Amanda Seidu, et al.
Published: (2022)